Skip to main content
Premium Trial:

Request an Annual Quote

IBS, Psychiatric Disorders Have Shared Genetic Architecture

Irritable bowel syndrome has a shared genetic architecture with psychiatric disorders and, to a lesser degree, with gastrointestinal ones, a team from the University of Oslo has found. The researchers amassed genome-wide association study datasets for IBS as well as for generalized anxiety disorder, schizophrenia, bipolar disorder, major depression, diverticular disease, and inflammatory bowel disease. As they report in Genome Medicine, the researchers analyzed the genetic architecture and genetic overlap of these conditions to find that IBS is highly polygenic and uncovered 132 loci independently associated with IBS. They also uncovered 70 loci shared by IBS and psychiatric disorders that implicate not only the gut-brain axis in IBS but also other processes like intestinal development and bone and reproductive physiology. "Furthermore, the pattern of genetic correlations and shared genomic loci with psychiatric disorders support the underlying genetic heterogeneity of IBS subtypes," the researchers write in their paper. "These genetic discoveries provide a better understanding of the pathophysiology of IBS potentially forming the basis for the development of more effective interventions."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.